Checkpoint inhibition could offer an effective treatment option for patients with rare cancer – News-Medical.Net

Peritoneal mesothelioma is cancer that develops in the lining of the abdomen, which is known as the peritoneum.
In a recent study from Rutgers Cancer Institute of New Jersey, researchers tested whether or not mesothelioma cancer cells express high amounts of PD-L1, a protein that is abundantly present on some types of cancer cells.
The PD-L1 protein is an inhibitory molecule that binds to the PD-1 receptor on T-cells, which are cells known to have the ability to recognize and destroy cancer cells…

Click here to view the original article.